Tiny synthetic particles could help scientists develop vaccines
against immune response diseases such as multiple sclerosis (MS),
research has shown.
The "nanoparticles" trick the immune system into behaving normally.
In tests on mice, they halted a rodent version of relapsing- remitting MS, the most common form of auto-immune disease.
Scientists believe the technology could be applied to a range of immune system disorders, including Type 1 diabetes, food allergies and asthma. MS occurs when the immune system attacks myelin, the fatty insulation that surrounds nerve fibres.
Breaks in the myelin coating prevent nerve messages being transmitted properly, leading to numbness, tingling and paralysis.
Professor Stephen Miller, from Northwestern University in Chicago, said: "This is a highly significant breakthrough in translational immunotherapy,"
The research appears in the journal Nature Biotechnology.
Most Popular Stories
- Americans Still Pessimistic Despite Economic Growth
- Illinois Issues Fracking Rules
- Detroit Muslim Conference Stirs Controversy
- 'Longmire' Cancelled, Looks for New Network
- Startups Offer Smartphone Banking Apps
- Clippers Deal Started With 2 Numbers
- Hip-Hop Takes Up Ferguson Cause
- Echeveste Steps Down, Perez Steps Up at VPE
- Immigration Delay Throws Both Parties a Curve
- Canada, Russia Go to War (on Twitter)